Ann: Positive feedback received on Paediatric Investigation Plan, page-53

If we could referring back to "New Data Supports ATL1102 broader Clinical Potential"

"Based on the positive outcomes from the protein analysis reported above, Australian Provisional Patent Application No. 2021903024 was filed 20 September 2021 with claims covering applications of ATL1102 in new potential disease settings including diabetic, respiratory and age-related diseases to support the Company’s future commercial and partnering plans for ATL1102."

Here are the major respiratory diseases:
1. Asthma
2. Chronic Obstructive Pulmonary Disease (COPD)
3. Pulmonary Fibrosis - Major pulmonary fibrosis include cystic fibrosis and idiopathic pulmonary fibrosis (IPF)

You would expect ANP towards this area along the way.. .the future looks bright to ANP indeed..